Antibe Therapeutics Inc(Pre-Merger) T.ATE

Zacks

[Amigo11]

Zacks out with an updated timeline/valuation 12 months out for $3. Per share of ATE-not quite sure why 500,000 were offered at the close at 39 cents.One side ,either the Buyers or the Sellers,is going to be horribly wrong !

[Marky1]

Amigo...Thank you for finding this information...What is the date that they come up with the target price of 3$ ?

[MHemorrhage]

Price targets are usually one year out.

[Marky1]

To go from .385$ to 3.00$ that's 675% increase ......kinda hard to believe, but, hey, we have a miracle drug at our feet, and it's going to change the entire drug industry....Soon, and I do believe, in 4 years when I graduate, I think that Otenaproxesul will be in everyones medical cabinet in every bathroom in North America, Japan and Europe, taking over the spot where Aspirin/ Tylenol

[drippingsnot]

At $3 we’re talking a billion dollar company.  That’s what the DCF is telling us along with the amazing Phase 2 data. Add to that, new IP to extend ATE’s lead into the future.  Assuming that’s what they are working on now. Improving our negotiating power and that’s what it’s all about now - in my opinion

[Goaweigh]

Is that before or after the 10 for 1 roll back ? The constant pressure on the stock may be because some anticipate a roll back is coming sooner than later. That's not all bad as long as it's executed properly and a US broker/ Marketing specialist has been retained to manage the stock properly through a US led financing or to make sure any stock coming out is well placed. Take a look at

[lscfa]

Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm engaged by the issuer for providing non-investment banking services to this issuer and expects to receive additional compensation for such non- investment banking services provided to this issuer. The non-investment banking services provided to the issuer includes

[Amigo11]

Are you trying to suggest that Research is usually impartial ? Nice to be Presbyterian on a Saturday night but that aint the way it works.

[lscfa]

Most recent report dropped target price to $2.25 https://s1.q4cdn.com/460208960/files/News/2020/Zacks_SCR_Research_08282020_ATBPF_Bautz.pdf

[Marky1]

That's USD !  Equivalent to $3.00 cdn

[Amigo11]

Its $2.25 US as previously stated but seriously am I going to be upset at $2.25 as to US or Cad-also regardless of who is paying for the research/promotion,it is well reasoned and well researched.To suggest that all research is impartial is ridiculous-there is always an agenda.

[TriumphSpitSix]

I made this clarification last time the Zack's valuation came up... This IS NOT a 12-month "price target." This is their assessment of Antibe's CURRENT VALUATION!